IGM Biosciences Inc

NASDAQ:IGMS   10:43:32 AM EDT
16.24
+0.61 (+3.90%)
Other Pre-Announcement

IGM Biosciences Announces First Quarter 2022 Results

Published: 05/09/2022 21:45 GMT
IGM Biosciences Inc (IGMS) - Igm Biosciences Announces First Quarter 2022 Financial Results and Provides Corporate Update.
For Q1 of 2022, Net Loss of $1.53 per Share.
Q1 Earnings per Share View $-1.61 -- Refinitiv Ibes Data (analyst estimates).
Cash and Investments As of March 31, 2022 Were $187.5 Million.
Reiterates Its Previously Issued Financial Guidance Expecting Full Year GAAP Operating Expenses of $250 Million to $260 Million.
Expects to End 2022 With a Balance of Over $390 Million in Cash and Investments.